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Caroline Alexander
University of Wisconsin-Madison
On ‘‘Short-Term Calorie Restriction
Enhances Skeletal Muscle Stem Cell
Function’’ by Cerletti et al., Cell Stem
Cell 10(5), 515–519, May 2012.
Perhaps it is not surprising that differen-
tiation is accompanied by major changes
in metabolism. During this transition the
cell changes from a streamlined division
machine to an efficient manufacturing
plant. However, it is more surprising to
think that metabolism and calorie sources
could be determinative for that process.
In their 2012 paper, Wagers and col-
leagues built on an emerging body of
data in support of this hypothesis. They
show that mice placed under a regimen
of calorie restriction show enhanced
muscle stem cell activity and vigor, both
in vitro and in vivo. Furthermore, this
property can be imposed on muscle
satellite cells from non-calorie-restricted
mice using a cocktail of drugs that
restricts the use of glycolysis as an energy
source. This finding correlates with the
increased mitochondrial content that
has been generally observed by gross
microscopy in calorie-restricted animals
for many years. Thus, this paper, together
with others, illustrates the power of
cellular biochemical processes as modi-
fiers of stem cell potential.648 Cell Stem Cell 12, June 6, 2013 ª2013 ERejuvenation by Macrophage
Hongkui Deng
Peking University
On ‘‘Rejuvenation of Regeneration in
the Aging Central Nervous System’’ by
Ruckh et al., Cell Stem Cell 10(1),
96–103, January 2012.
A key question in the study of aging is
what the factors are that limit the regener-
ative capacity of various tissues with age.
Using heterochronic parabiosis between
old and young mice mice, Ruckh et al.
found that macrophages from young
GFP-tagged mice were recruited to the
site of a demyelinated lesion in old mice
and enhanced remyelination by oligoden-
drocyte precursor cells (OPCs) in the
central nervous system (CNS). The under-
lying mechanism seems to involve clear-
ance of inhibitory myelin debris by the
young macrophages. This finding indi-
cates that the age-related decline in
OPC remyelination is dependent on envi-
ronmental rather than inherent factors
and can be regulated by a change in the
extrinsic environment. Previous studies
have shown that factors secreted by im-
mune cells affect neural regeneration.
This study suggests an unanticipated
approach to promoting neural regenera-
tion by utilizing macrophage phagocytic
activity. It also challenges many of our
assumptions regarding the regenerative
potential of the CNS and the regulatory
mechanisms underlying aging and pro-
vides a new basis to consider when
designing therapies for demyelination
diseases such as multiple sclerosis.lsevier Inc.Polycomb Complexity
Stuart Orkin
Harvard University/HHMI
On ‘‘Ezh1 Is Required for Hematopoietic
Stem Cell Maintenance and Prevents
Senescence-like Cell Cycle Arrest’’ by
Hidalgo et al., Cell Stem Cell 11(5), 649–
662, November 2012.
Polycomb group proteins are important
epigenetic regulators of cell fates and
development. The Polycomb Complex-2
(PRC2) deposits the ‘‘repressive’’ mark
H3K27me3, catalyzed by the core
component Ezh2. Despite early recogni-
tion of Ezh1 as a close homolog, most
studies historically focused exclusively
on Ezh2. Work in 2008 showed that Ezh1
associates with the other PRC2 core
components EED and Suz12 to form an
alternative PRC2 complex that compen-
sates for loss of the Ezh2-containing
PRC2 complex in ESCs, and potential
functions of Ezh1 beyond the canonical
PRC2 complex have also been sug-
gested. I found the paper from Hidalgo
et al. notable because it provides evi-
dence that Ezh1 plays a role in vivo within
the setting of hematopoietic stem cell
(HSC) maintenance. This paper com-
plements reports that underscore
increasing complexity in the composition
and context-specific functions of PRC2
and its various subunits in stem cell
biology. Although its mechanism is not a
focus of the paper, the normal level of
H3K27me3 in Ezh1-knockout HSCs is
consistent with noncanonical roles of
Ezh1. I suspect that we have much to
learn about the constituents of PRC2,
particularly beyond ESCs where much
attention has been paid.
Cell Stem Cell
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Iannis Aifantis
New York University/HHMI
On ‘‘Bone Marrow Failure in Fanconi
Anemia Is Triggered by an Exacerbated
p53/p21 DNA Damage Response that
Impairs Hematopoietic Stem and Progen-
itor Cells’’ by Ceccaldi et al., Cell Stem
Cell 11(1), 36–49, July 2012.
One of the most fascinating areas in
stem cell biology is the close relationship
between physiological stem cell self-
renewal/differentiation and stem cell pa-
thology that leads to disease. In their
2012 paper, Soulier and colleagues
made a connection between Fanconi
Anemia (FA), a disease in which patients
undergo progressive bonemarrow failure,
and the DNA damage response in
hematopoietic stem cells (HSCs). The
authors found, using a beautiful combina-
tion of animal modeling and studies with
primary human FA bone marrow cells,
that FA patients show progressive and
profound defects in HSC function that
are present before the onset of the dis-
ease. In response to replicative stress,
FA stem and progenitor cells mount an
aberrant p53-mediated DNA damage
response leading to a cell cycle arrest
that is dependent on the induction of the
inhibitor p21Cdkn1a. p53 and p21 silencing
rescued the resulting hematopoietic de-
fects in vitro and in vivo. This manuscript
offered a fresh take on the mechanism
that underlies FA, the most common
type of bone marrow failure, and re-
minded us how disruption of the critical
balance between physiological and
aberrant stem cell function can frequently
lead to the induction of disease.Wnt and Mammary Stem Cells
Hans Clevers
Hubrecht Institute
On ‘‘Developmental Stage and Time
Dictate the Fate of Wnt/b-Catenin-
Responsive Stem Cells in the Mammary
Gland’’ by van Amerongen et al., Cell
Stem Cell 11(3), 387–400, September
2012.
Ever since Roel Nusse cloned the first
Wnt gene as an oncogene in the mam-
mary gland with Varmus in 1984, his lab
has been studying aspects of the Wnt
pathway. In the mid-90s, it emerged that
Wnt signals represent a major driving
force of adult stem cells. Wnt signals ulti-
mately activate b-catenin/TCF target
genes, and among these the Axin2 gene
stands out as a ‘‘generic’’ Wnt/TCF target
in a wide range of embryonic and adult
tissues. In their 2012 paper, the Nusse
lab closed the Wnt/adult stem cell/cancer
circle for the organ in which Wnt was
originally defined. They generated an
Axin2CreERT2 allele and performed genetic
lineage tracing of Wnt-responsive cells.
Although tracing in the mammary placode
before birth led to long-term labeling
of only luminal cells, tracing induced
in prepubertal mice uniquely labeled
basal stem cells. These results confirmed
an earlier observation that mammary
stem cells, which are bipotent in trans-
plantation assays, behave as unipotent
stem cells in situ. However, when fol-
lowed through multiple pregnancies, the
Axin2+ cells build complete alveolar
structures, showing that they are long-
lived, self-renewing, and bipotent. In other
words, these Wnt-driven cells are the
stem cells of the adult mammary gland,
with time and context-dependent lineage
contributions.Cell Stem CeTinkering with HSC Brakes
Hanna Mikkola
University of California, Los Angeles
On ‘‘Attenuation of miR-126 Activity
Expands HSCs In Vivo without Exhaus-
tion’’ by Lechman et al., Cell Stem Cell
11(6), 799–811, December 2012.
Despite intense efforts, there has been
little success in developing robust, clini-
cally applicable protocols for the expan-
sion of human hematopoietic stem cells
(HSCs). Stimulation of HSCs in culture
disrupts self-renewal, and genetic manip-
ulation of HSC quiescence results in HSC
exhaustion, poor engraftment, or malig-
nant transformation, suggesting that
loosening the brakes in HSCs may send
them permanently on the wrong path.
Lechman et al. have provided new hope.
Using lentiviral vector sponges to ablate
miR-126, they were able to improve the
long-term reconstitution capacity of
both mouse and human HSCs. The effect
was explained by increased cytokine
responsiveness and loss of quiescence
in HSCs and wasmediated by heightened
PI3K/AKT signaling. Remarkably, the
increased cycling did not lead to HSC
exhaustion or malignancy, suggesting
that manipulation of microRNAs may
provide a new, safer approach for
HSC expansion. These findings make
me intrigued about the function of the
microRNA machinery in governing the
different proliferative properties of fetal,
adult, and aged HSCs. They also open
the door to exploring whether a combina-
tion of miR-126 knockdown and cell-
based in vitro culture systems or small
molecules has a synergistic effect on
HSC expansion or even promotes HSC





On ‘‘Cdc42 Activity Regulates Hemato-
poietic Stem Cell Aging and Rejuvena-
tion’’ by Florian et al., Cell Stem Cell
10(5), 520–530, May 2012.
The primary sites and patterns of
hematopoiesis change during mouse
development, and, surprisingly, also
become distinctly different as mice age.
Aged murine hematopoietic stem cells
(HSCs) show increased myelopoiesis but
reduced erythropoiesis and lymphopoie-
sis, diminished homing and engraftment
capacity, and decreased self-renewal
activity. I was intrigued by the report by
Florian et al. that aged HSCs also display
differences in the levels and polarized
localizations of the RhoGTPase Cdc42.
They found that HSCs from young mice
showed concentrations of Cdc42 and
tubulin in the immediate pericentriolar
zone along a nuclear/centrosome/cell
membrane axis. In contrast, Cdc42 and
tubulin were distributed throughout the
cell body in an unpolarized fashion in
aged HSCs. Strikingly, pharmacological
inhibition of Cdc42 activity functionally
rejuvenated aged HSCs to levels similar
to those in young HSCs and increased
the percentage of polarized cells. Inhibi-
tion of Cdc42 activity also restored the
level and spatial distribution of histone
H4 lysine 16 acetylation, an epigenetic
change that could explain the somewhat
persistent effects of Cdc42 inhibition in
aged HSCs that received a single treat-
ment with the pharmacological inhibitor.
Whether this Cdc42-polarity pathway
influences aging in other stem cell popu-
lations is food for thought.650 Cell Stem Cell 12, June 6, 2013 ª2013 EEyeing Eye Regeneration
Huck Hui Ng
Genome Institute of Singapore
On ‘‘Self-Formation of Optic Cups and
Storable Stratified Neural Retina from
Human ESCs’’ by Nakano et al., Cell
Stem Cell 10(6), 771–785, June 2012.
Application of human pluripotent stem
cells (hPSCs) for research or clinical use
is limited by the challenges associated
with efficient derivation of pure popula-
tions of differentiated cell types such as
neurons or cardiomyocytes. Beyond the
paradigm of lineage-specific differentia-
tion, hPSCs can potentially be guided to
form complex structures comprising
various different cell types. However,
examples of such differentiation are rare
because suitable culture conditions are
difficult to establish. In their 2012 paper,
Sasai’s lab described the generation of
optic cup and derivation of neural retina
from human ESCs, building on their
previous generation of an optic cup from
mouse ESCs. Through a painstaking
effort to optimize differentiation, they
successfully differentiated human ESCs
into retinal epithelium, which underwent
self-organization to form optic vesicles.
The most strikingly result was the demon-
stration that stratified fetal-like neural
retina tissues containing multiple cell
types (photoreceptors, ganglion cells,
and interneuron precursors) can be
generated in a spatially organized
manner. Although this field is still some
way from clinical application, further
refinement and development of the meth-
odologymay one day enable replacement
of damaged retinal tissues.lsevier Inc.Polycomb Switch-Off
Kathrin Plath
University of California, Los Angeles
On ‘‘Polycomb Associates Genome-wide
with a Specific RNA Polymerase II Variant
and Regulates Metabolic Genes in ESCs’’
by Brookes et al., Cell Stem Cell 10(2),
157–170, February 2012.
Decades of work has established that
Polycomb proteins repress transcription
within the context of repressor complexes
(PRCs). Paradoxically, though, PRCs are
often found at actively transcribed loci,
including many critical components of
the pluripotency network, and are appar-
ently positioned with the elongating
form of RNA polymerase II (RNAPII). The
functional role of this association has
been unclear. I got excited about this
paper from the Pombo group because it
uses an elegant combination of single-
cell and genome-wide analysis to show
that these highly expressed PRC-bound
genes are typically not simultaneously
transcribed and repressed. Instead, they
switch between active and repressed
states. Thus, ESC cultures are a hetero-
geneous mixture in which many genes
have clearly distinct epigenetic states in
individual cells. This heterogeneity may
be both a cause and a consequence of
the cell-to-cell variation in expression
seen for important pluripotency regula-
tors. We also learned from this paper
that the coding region of PRC-repressed
genes contains a nonelongating form of
RNAPII that is still able to establish active
chromatin marks, leading to the previ-
ously described chromatin bivalency.
Overall, therefore, this paper helps define
the diverse functions of PRCs in ESCs and
the underlying basis of heterogeneity in
ESC cultures.
Cell Stem Cell
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Emmanuelle Passegue´
University of California, San Francisco
On ‘‘Temporal Changes in PTEN and
mTORC2 Regulation of Hematopoietic
Stem Cell Self-Renewal and Leukemia
Suppression’’ by Magee et al., Cell Stem
Cell 11(3), 415–428, September 2012
and ‘‘mTORC Complex 1 Plays Critical
Roles in Hematopoiesis and Pten-Loss-
Evoked Leukemogenesis’’ by Kalaitzidis
et al., Cell Stem Cell 11(3), 429–439,
September 2012.
These two articles particularly struck
me because they highlight one emerging
features of hematopoietic stem cell
(HSC) biology: how mechanisms de-
signed to maximize the regenerative
capability of dormant HSCs are often
dispensable during embryogenesis and
can be hijacked in leukemia. Both studies
use powerful mouse genetics to examine
the regulation of the PI3K/AKT pathway
by the mTOR kinase and its two regula-
tory complexes, mTORC1 (raptor) and
mTORC2 (rictor). They found that
increased PI3K activity, via Pten deletion,
is leukemogenic only in adult HSCs, and
that among the mTOR complexes, only
mTORC1 is essential to modulate PI3K
activity at steady state and keep HSCs
in check. In contrast, they show that
both mTORC1 and mTORC2 are required
for the aberrant growth of transformed
HSCs. Together, these papers delve into
some of the complexity of the signaling
networks controlling HSC growth and
describe how the metabolic pathways
that help regulate blood production in
adults actually render HSCs susceptible
to leukemic transformation. Finally, they
provide a glimpse into possible therapeu-
tic strategies aimed at blocking the




On ‘‘Esrrb Is a Pivotal Target of the Gsk3/
Tcf3 Axis Regulating Embryonic Stem
Cell Self-Renewal’’ by Martello et al., Cell
Stem Cell 11(4), 491–504, October 2012.
Mouse embryonic stem cells (ESCs) are
efficiently maintained in a naive state by
culture in Lif and ‘‘2i,’’ two inhibitors of
the Erk and Gsk3 pathways, respectively.
Although Tcf3 was known to be the
immediate downstream effector of Gsk3
inhibition, the functionally relevant target
or targets of Tcf3 remained elusive. In
their 2012 paper, Martello et al. showed
that the gene encoding the nuclear
receptor Esrrb is a direct downstream
target of Tcf3 and that its expression is
sufficient and required to maintain ESCs
in a naive state in a Gsk3-dependent
manner. Moreover, they also found that
the Gsk3-Tcf3-Esrrb axis acts in parallel
to the LIF-Stat3 pathway, thus conferring
unexpected flexibility and robustness on
maintenance of the naive ESC state.
I enjoyed reading this paper for several
reasons. First, this report extended semi-
nal work by the same group on LIF-Stat3
signaling to another key pathway whose
constituents and functional roles in self-
renewal had not been definitively estab-
lished. Second, the authors’ approach of
combining available functional genomics
data with their own expression data was
a simple yet powerful approach to identify
Esrrb as the main effector of Gsk3/Tcf3.
Lastly, I liked the authors’ choice of
elegant genetic tools to define require-
ment, sufficiency, and epistasis of Esrrb
within the core pluripotency network.Cell Stem CeA Dynamic Developmental Duo
Elaine Dzierzak
Erasmus MC
On ‘‘Hematopoietic Stem Cell Subtypes
Expand Differentially during Development
and Display Distinct Lymphopoietic
Programs’’ by Benz et al., Cell Stem Cell
10(3), 273–283, March 2012.
Although the paradigm of hematopoiet-
ic stem cell (HSC) heterogeneity is widely
accepted, the study by Benz et al. caught
my eye because it explored the dynamics
of this heterogeneity during fetal to adult
stages. Over 10 years ago, in vivo trans-
plantation experiments revealed that
two distinct subtypes of self-renewing
HSCs coexist in the mouse bone marrow;
one subtype has a balanced myeloid-
lymphoid differentiation output (b HSCs)
and a second subtype has a myeloid-
biased output (a HSCs). Myeloid-biased
a HSCs are known to predominate in
aged mice. This new study shows that
b HSCs predominate (10-fold more than
a HSCs) in the fetal liver and that there is
a progressive increase in the ratio of a to
b HSCs from postnatal stages onward.
Stability in the differentiation programs
of individual a and b HSC clones was
revealed in serial transplants. While it is
not surprising that some b clones pro-
duced a clones, in some rare cases a
clones reactivated the lymphoid program,
indicating that the HSC state is reversible
or reprogrammable. The discovery that
the ratio of two HSC subtypes is dynamic
through developmental time serves as a
basis for further studies that could provide
insight into the biological/functional rele-
vance of this duo, what intrinsic/extrinsic
factors influence the subtype changes,
and whether all HSCs begin life as b cells.ll 12, June 6, 2013 ª2013 Elsevier Inc. 651
